Postadolescent changes in regional cerebral protein synthesis: An in vivo study in the Fmr1 null mouse

Journal of Neuroscience

Volumn 25, Issue 20, 2005, Pages 5087-5095

  Qin, Mei ^a   Kang, Julia ^a   Burlin, Thomas V ^a   Jiang, Chunhui ^a   Smith, Carolyn Beebe ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Age; FMRP; Fragile X; Protein synthesis; Synaptic plasticity; Synaptic pruning

Indexed keywords

BRAIN PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; FEMALE; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; WILD TYPE;

AGE FACTORS; ANIMALS; AUTORADIOGRAPHY; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; LEUCINE; MICE; MICE, KNOCKOUT; ORGAN SIZE; PROTEIN BIOSYNTHESIS; TIME FACTORS; TRITIUM;

EID: 19044372933     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0093-05.2005     Document Type: Article

References (53)

1. Agranoff BW (1981) Learning and memory: biochemical approaches. In: Basic neurochemistry (Seigel GJ, Albers RW, Agranoff BW, Katzman R, eds), pp 801-820. Boston: Little, Brown and Company.
2. Antar LN, Afroz R, Dictenberg JB, Carroll RC, Bassell GJ (2004) Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and frma mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648-2655.
3. Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW (2005) The fragile X mental retardation protein and group 1 metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci USA 102:2180-2185.
4. Baubet V, Grange E, Sermet E, Giaume M, Gay N, Bobillier P (1996) Widespread increase in brain protein synthesis following acute immobilization stress in adult rat brain. Neurosci Lett 219:187-190.
5. Bear M, Huber KM, Warren ST (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370-377.
6. Beckel-Mitchener AC, Churchill JD, Kim S, Estrada CM, Greenough WT (2003) Prolonged elevation of serum glucocorticoid (corticosterone) levels in fragile X knockout mice after acute stress. Soc Neurosci Abstr 29:646.5.
7. Boccia ML, Roberts JE (2000) Behavior and autonomic nervous system function assessed via heart period measures: the case of hyperarousal in boys with fragile X syndrome. Behav Res Methods Instrum Comput 32:5-10.
8. Brown V, Vin P, Ceman S, Darnell JC, O'Donnell WR, Tennenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD (2001) Microarray identification of FMRP associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487.
9. Caudy AA, Myers M, Hannon GJ, Hammond SM (2002) Fragile X related protein and VIG associate with the RNA interference machinery. Genes Dev 16:2491-2496.
10. Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050.
11. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X permutation. Nat Genet 4:335-340.
12. Dutch-Belgian Fragile X Consortium (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33.
13. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM (1997) Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
14. Giaume M, Grange E, Baubet V, Gay N, Sermet E, Sarda N, Bobillier P (1995) Cerebral protein synthesis alterations in response to acute and chronic immobilization stress in the rat. Brain Res 675:121-126.
15. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2:861-863.
16. Hagerman RJ (2002) The physical and behavioral phenotype. In: Fragile X syndrome: diagnosis, treatment, and research (Hagerman RJ, Hagerman PJ, eds) pp 3-109. Baltimore: Johns Hopkins UP.
17. Hessl D, Glaser B, Dyer-Friedman J, Blasey C, Hastie T, Gunnar M, Reiss AL (2002) Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology 27:855-872.
18. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD (1991) Analysis of neocortex in three males with fragile X syndrome. Am J Med Genet 41:289-294.
19. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
20. Huber KM, Gallagher SM, Warren ST, Bear MF (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746-7750.
21. Irwin SA, Idupulapati M, Gilbert ME, Harris JB, Chakravarti AB, Rogers EJ, Crisostomo R, Larsen BP, Mehta A, Alcantara CJ, Patel B, Swain R, Weiler IJ, Oostra BA, Greenough WT (2002) Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X mice. Am J Med Genet 111:140-146.
22. Ishizuka A, Siomi MC, Siomi HA (2002) Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 16:2497-2508.
23. Ivanco TL, Greenough WT (2002) Altered mossy fiber distributions in adult fmr1 (FVN) knockout mice. Hippocampus 12:47-54.
24. Kooy RF (2003) Of mice and the fragile X syndrome. Trends Genet 19:148-154.
25. Laggerbauer B, Ostareck D, Keidel E-M, Ostareck-Lederer A, Fischer U (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Gen 10:329-338.
26. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y (2001) The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res 29:2276-2283.
27. Linden DJ (1996) A protein synthesis-dependent late phase of cerebellar long-term depression. Neuron 17:483-490.
28. Lu R, Wang H, Liang Z, Ku L, O'Donnell WT, Li W, Warren ST, Feng Y (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci USA 101:15201-15206.
29. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME (1999) Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785-790.
30. Marin-Padilla M (1967) Number and distribution of the apical dendritic spines of the layer V pyramidal cells in man. J Comp Neurol 131:475-489.
31. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Neitzel K, Stackhouse T, Hagerman RJ (1999) Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 83:268-279.
32. Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann SD, Droste SK, Kuhn R, Reul JMHM, Holsboer F, Wurst W (2003) Limbic corticotrophin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6:1100-1107.
33. Nguyen PV, Abel T, Kandel ER (1994) Requirement of a critical period of transcription for induction of a late-phase of LTP. Science 265:1104-1107.
34. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. New York: Academic.
35. Qin M, Kang J, Smith CB (2002) Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:15758-15763.
36. Qin M, Kang J, Smith CB (2003) Rates of cerebral protein synthesis increased in fragile X knockout mice in vivo. Soc Neurosci Abstr 29:646.8.
37. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddelena R, Spiegel R, Schnizel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, et al. (1994) A multicenter study on genotype-phenotype correlations in fragile X syndrome, using direct diagnosis with probe StB12:3: the first 2253 cases. Am J Hum Genet 55:225-237.
38. Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure-Kamionowska M, Connell F, Wisniewski HM (1985) Adult fragile X syndrome: cliniconeuropathologic findings. Acta Neuropath (Berl) 67:289-295.
39. 11C]leucine and PET with correction for recycling of tissue amino acids. I. Kinetic modeling approach. J Cereb Blood Flow Metab 25:617-628.
40. Shigemoto R, Mizuno N (2000) Metabotropic glutamate receptors- immunochemical and in situ hybridization analyses. In: Handbook of chemical neuroanatomy, Vol 18, Glutamate (Ottersen OP, Storm-Mathisen J, eds), pp 63-98. Amsterdam: Elsevier.
41. Smith CB (1983) Localization of activity-associated changes in metabolism of the central nervous system with the deoxyglucose method: prospects for cellular resolution. In: Methods in cellular neurobiology, Vol 1 (Barker JL, McKelvey JF, eds), pp 269-317. New York: Wiley.
42. Smith CB, Kang J (2000) Cerebral protein synthesis in a genetic mouse model of phenylketonuria. Proc Natl Acad Sci USA 97:11014-11019.
43. Smith CB, Deibler GE, Eng N, Schmidt K, Sokoloff L (1988) Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation. Proc Natl Acad Sci USA 85:9341-9345.
44. Smith CB, Sun Y, Sokoloff L (1995) Effects of aging on regional rates of cerebral protein synthesis in the Sprague-Dawley rat: examination of the influence of recycling of amino acids derived from protein degradation into the precursor pool. Neurochem Int 27:407-416.
45. 11C]leucine and PET with correction for recycling of tissue amino acids. II. Validation in rhesus monkeys. J Cereb Blood Flow Metab 25:629-640.
46. Steward O, Schuman EM (2001) Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24:299-325.
47. Sun Y, Deibler GE, Sokoloff L, Smith CB (1992) Determination of regional rates of cerebral protein synthesis in conscious adult rats adjusting for regional differences in recycling of leucine derived from protein degradation into the precursor pool. J Neurochem 59:863-873.
48. Sun Y, Deibler GE, Jehle J, Macedonia J, Dumont I, Dang T, Smith CB (1995) Rates of local cerebral protein synthesis in the rat during normal postnatal development. Am J Physiol 268:R549-R561.
49. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazleton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
50. Weiler IJ, Spangler CC, Klintsova AY, Grossman AW, Kim SH, Bertaina-Anglade V, Khaliq H, de Vries FE, Lambers FAE, Hatia F, Base CK, Greenough WT (2004) Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci USA 101:17504-17509.
51. West AE, Chen WG, Dalva MB, Dolmetsh RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME (2001) Calcium regulation of neuronal gene expression. Proc Natl Acad Sci USA 98:11024-11031.
52. Wisbeck JM, Huffman LC, Freund L, Gunnar M, Davis EP, Reiss AL (2000) Cortisol and social stressors in children with fragile X syndrome: a pilot study. J Dev Behav Pediatr 21:278-282.
53. Zhang YQ, Bailey AM, Matthies HJG, Benden RB, Smith MA, Speese SD, Rubin GM, Broadie K (2001) Drosophila fragile X-related gene regulates the MAP1B homolog futsch to control synaptic structure and function. Cell 107:591-602.